Loading
A phase 3 trial of HPV quadrivalent vaccine in penile cancer, run by Shanghai Bovax Biotechnology Co., Ltd., active and no longer recruiting.
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males is a phase 3 interventional study registered as NCT06465914 by Shanghai Bovax Biotechnology Co., Ltd., with 9000 participants enrolled, started 2024-07-11 and due to reach its primary completion in 2027-07-30. Interventions recorded: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha), Placebo. Conditions listed: Genital Wart, Penile Cancer, Anal Cancer, PIN-1. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Shanghai Bovax Biotechnology, HPV quadrivalent vaccine (types 6, 11, 16 and 18), Cancer interception vaccines, HPV & HBV vaccination.
Shares HPV quadrivalent vaccine (types 6, 11, 16 and 18), Cancer interception vaccines, HPV & HBV vaccination.
Shares Localised penile cancer (organ-confined, node-negative), Penile cancer, HPV & HBV vaccination.
Shares HPV quadrivalent vaccine (types 6, 11, 16 and 18), Localised penile cancer (organ-confined, node-negative), Penile cancer, HPV & HBV vaccination.
Shares Localised penile cancer (organ-confined, node-negative), Penile cancer.
Shares Localised penile cancer (organ-confined, node-negative), Penile cancer.
Shares Localised penile cancer (organ-confined, node-negative), Penile cancer, HPV & HBV vaccination.
Shares Shanghai Bovax Biotechnology, HPV quadrivalent vaccine (types 6, 11, 16 and 18), Penile cancer, HPV & HBV vaccination.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/